MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE:MDT) today announced the publication of results from a multicenter, prospective study that demonstrated that the company’s Reveal ® Plus ...
Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...
July 14--A device a fraction of an inch long is providing George Saenz with a peace of mind he has never had before. Three weeks ago, the 67-year-old independent insurance agent had the Medtronic ...
Please provide your email address to receive an email when new articles are posted on . Immediate insertion of a cardiac monitor following first cryptogenic stroke was cost-effective in the U.S.
Our study estimates more accurately the incidence of rhythm disturbances in patients with obstructive apnea-hypopnea syndrome and the impact of CPAP therapy. The study's 16 men and seven women with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback